SavedAdd your journal

Journals / Ortadoğu Tıp Dergisi / 2019 / Cilt: 11 - Sayı: 4

Peritonitis due to carbapenem resistant, multidrug resistant Acinetobacter baumannii in a patient with continuous ambulatory peritoneal dialysis following the polymicrobial infective endocarditis

Sürekli ayaktan periton diyalizi hastasında polimicrobiyal infektif endokarditi takiben gelişen karbapeneme dirençli, çoklu ilaca dirençli Acinetobacter baumannii’ye bağlı olarak gelişen peritonit

Pınar GÜRKAYNAK
Salih CESUR
Şerife ALTUN DEMİRCAN
Şükran SEVİM
Çiğdem ATAMAN HATİPOĞLU
Sami KINIKLI
Gül GÜRSOY
Pages
621–625
Publication Date
2019-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, peritonitis due to A.baumannii following the polymicrobial infective endocarditis in a female patient who underwent peritoneal dialysis due to chronic renal insufficiency at the age of 60 years has been reported and the literature has been reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Carbapenems resistant, multi drug resistant Acinetobacter baumannii (A.baumannii) infections are important health-care-associated infections and cause mortality and morbidity.
📊
Key Findings & Data:Peritonitis due to multidrug resistant A.baumannii is rarely reported.
💡
Conclusion & Impact:In this article, peritonitis due to A.baumannii following the polymicrobial infective endocarditis in a female patient who underwent peritoneal dialysis due to chronic renal insufficiency at the age of 60 years has been reported and the literature has been reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Acinetobacter baumannii · peritonit · çoklu ilaca direnç

Abstract

Carbapenems resistant, multi drug resistant Acinetobacter baumannii (A.baumannii) infections are important health-care-associated infections and cause mortality and morbidity. Peritonitis due to multidrug resistant A.baumannii is rarely reported. Treatment of peritonitis due to multidrug resistant A.baumannii is difficult. In this article, peritonitis due to A.baumannii following the polymicrobial infective endocarditis in a female patient who underwent peritoneal dialysis due to chronic renal insufficiency at the age of 60 years has been reported and the literature has been reviewed.

Özet

Karbapeneme dirençli, çoklu ilaca diençli Acinetobacter baumannii (A.baumannii) infeksiyonları sağlık bakımı ile ilişkili infeksiyonların önemli bir etkeni olup, mortalite ve morbidite nedenidir. Çoklu ilaca dirençli A.baumannii’ye bağlı peritonit nadiren bildirilmektedir. Çoklu ilaca dirençli A.baumannii’ye bağlı olarak gelişen peritoniterin tedavisi güçtür.Bu yazıda, 60 yaşında kronik böbrek yetmezliği nedeniyle periton diyalizi uygulanan bir kadın hastada polimikrobiyal infektif endokarditi takiben A.baumannii’ye bağlı olarak gelişen ve mortal seyreden peritonit bildirilmiş ve literatür gözden geçirilmiştir.

🔖

Cite This Article

GÜRKAYNAK, P., CESUR, S., DEMİRCAN, Ş. A., SEVİM, Ş., HATİPOĞLU, Ç. A., KINIKLI, S., GÜRSOY, G. (2019). Peritonitis due to carbapenem resistant, multidrug resistant Acinetobacter baumannii in a patient with continuous ambulatory peritoneal dialysis following the polymicrobial infective endocarditis. Ortadoğu Tıp Dergisi, Cilt: 11 - Sayı: 4, 621–625. https://ajindex.com/articles/82656

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Acinetobacter infection: Treatment and prevention. https://www.uptodate.com/contents/acinetobacter-infection-treatment-and-prevention Phillips M. Acinetobacter Species. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edi. Elsevier Company: 2552-2558.
  2. Blanco N, Harris AD, Rock C, Johnson JK, ve ark. Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission. Antimicrob Agents Chemother. 2017; 62(1) pii: e01631-17. Almomani BA, McCullough A, Gharaibeh R, Samrah S, Mahasneh F. Incidence and predictors of 14-day mortality in multidrug-resistant Acinetobacter baumannii in ventilator-associated pneumonia. J Infect Dev Ctries. 2015; 9(12): 1323-30.
  3. Zhang W, Wu YG, Qi XM, Dai H, Lu W, Zhao M. Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases. Perit Dial Int. 2014; 34(3): 317-21.
  4. Fitzpatrick MA, Esterly JS, Postelnick MJ, Sutton SH. Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactam. Ann Pharmacother. 2012; 46(7-8): e17. Chao CT, Lee SY, Yang WS,ve ark. Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time. PLoS One. 2014; 9 (10): e110315. Zarakolu P, Ayaz ÇM, Metan G. Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016). Mikrobiyol Bul. 2018; 52(2): 190-197.
  5. Warner WA, Kuang SN, Hernandez R, ve ark. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA. BMC Infect Dis. 2016; 16: 194. Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chemother. 2018; 24(7): 515-523.
  6. Begum S, Hasan F, Hussain S, Ali Shah A. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pak J Med Sci. 2013; 29(5): 1253-8. García-Granja PE, López J, Vilacosta I, Ortiz-Bautista C, Sevilla T, Olmos C, ve ark. Polymicrobial Infective Endocarditis: Clinical Features and Prognosis. Medicine (Baltimore). 2015; 94(49): e2000.
  7. Chrissoheris MP, Libertin C, Ali RG, Gha